Explain the principles of chemotherapy for neoplastic diseases in animals.
15 marks · directive: Explain
The core of a good answer
Chemotherapy for animal tumours rests on fractional kill (each dose kills only a fraction of tumour cells, so cycles are repeated), choice of drugs by their action on the cell cycle, combinations of drugs with different mechanisms and side effects to limit resistance and toxicity, dosing by body surface area, timing as neoadjuvant or adjuvant therapy with surgery or radiation, and safe handling of drugs and of the patient's excreta.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Explain the principles that guide drug selection, combination, dosing, timing, toxicity and safety in cancer chemotherapy, with veterinary examples such as canine transmissible venereal tumour and canine mast cell tumour.
Answer outline
Introduction
Chemotherapy uses drugs to kill or control neoplastic cells. In animals it is used alone or together with surgery and radiotherapy, and the principles below decide which drugs are given, how much, when and how safely.
Action on the cell cycle
- Alkylating agents act at any point in the cell cycle (cell cycle independent) and their effect is dose dependent.
- Antimetabolites are cell cycle dependent and act in S phase, when DNA is synthesised.
- Vinca alkaloids such as vincristine are cell cycle specific, acting in S phase and disrupting M phase; anti microtubule drugs can also affect blood vessel growth.
- Knowing the phase of action helps in combining and scheduling drugs.
Fractional kill and repeated cycles
- Only a fraction of the cells in a tumour die with each treatment, so repeated doses and cycles are needed to reduce the tumour burden.
Combination chemotherapy
- The biggest advantage is minimising the chance of resistance to any one agent.
- Drugs with different mechanisms and side effects can often be used at lower doses, which reduces toxicity.
- Drug efflux by P glycoprotein has been suggested as a major mechanism of resistance.
Dosing and timing
- The standard method of setting the dose is by calculated body surface area, although this gives considerable variation in drug concentrations.
- Neoadjuvant chemotherapy is given before local treatment to shrink the primary tumour; adjuvant chemotherapy follows surgery or radiotherapy to reduce the risk of recurrence.
Toxicity and monitoring
- Cardiotoxicity is especially prominent with anthracyclines such as doxorubicin.
- Peripheral intravenous administration carries a risk of phlebitis and extravasation; central venous access is less prone to these.
Safety of handlers and owners
- Drugs are prepared in biological safety cabinets; malfunctioning cabinets have exposed personnel to antineoplastic drugs.
- Drugs leave the patient in urine, faeces, vomit, sweat and saliva, mostly within 24 hours to 7 days, so excreta of treated animals must be handled with care.
Veterinary examples
- Canine transmissible venereal tumour regresses when treated with vincristine, as the host immune system is activated; spontaneous regression can also occur.
- Toceranib, a receptor tyrosine kinase inhibitor, is indicated for canine cutaneous mast cell tumours.
Conclusion
Effective veterinary chemotherapy combines tumour biology (cell cycle and fractional kill) with rational combinations, body surface area dosing, proper timing around surgery and radiation, and careful attention to toxicity and handler safety.
Examples and data to cite
- Toceranib phosphate, approved by the US FDA in 2009 as the first drug to treat cancer in dogs, for canine cutaneous mast cell tumours.
- Canine transmissible venereal tumour, which regresses when treated with vincristine.
Facts to remember
- Alkylating agents are cell cycle independent; antimetabolites act in S phase; vinca alkaloids are cell cycle specific and disrupt M phase.
- Each chemotherapy dose kills only a fraction of tumour cells, so repeated cycles are required.
- Body surface area dosing is the standard method for chemotherapy doses.
- Anthracyclines such as doxorubicin are associated with cardiotoxicity.